Determining the genomic basis of PAX3-FOXO1 mediated transformation in rhabdomyosarcoma

被引：0
|
作者：
Stevens, Bradley T.
Zhang, Yang
Larsen, Randolph K.
Adkins, Grace E.
Hopkins, Jack D.
Kimbrough, Darden W.
Garcia, Matthew R.
Abraham, Brian J.
Hatley, Mark E.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
    Cassandri, Matteo
    Pomella, Silvia
    Rossetti, Alessandra
    Petragnano, Francesco
    Milazzo, Luisa
    Vulcano, Francesca
    Camero, Simona
    Codenotti, Silvia
    Cicchetti, Francesca
    Maggio, Roberto
    Festuccia, Claudio
    Gravina, Giovanni Luca
    Fanzani, Alessandro
    Megiorni, Francesca
    Catanoso, Marialuigia
    Marchese, Cinzia
    Tombolini, Vincenzo
    Locatelli, Franco
    Rota, Rossella
    Marampon, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [42] RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy
    Rengaswamy, Venkatesh
    Zimmer, Doris
    Suess, Regine
    Roessler, Jochen
    JOURNAL OF CONTROLLED RELEASE, 2016, 235 : 319 - 327
  • [43] KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
    Kim, Yong Yean
    Gryder, Berkley E.
    Sinniah, Ranuka
    Peach, Megan L.
    Shern, Jack F.
    Abdelmaksoud, Abdalla
    Pomella, Silvia
    Woldemichael, Girma M.
    Stanton, Benjamin Z.
    Milewski, David
    Barchi Jr, Joseph J.
    Schneekloth Jr, John S.
    Chari, Raj
    Kowalczyk, Joshua T.
    Shenoy, Shilpa R.
    Evans, Jason R.
    Song, Young K.
    Wang, Chaoyu
    Wen, Xinyu
    Chou, Hsien-Chao
    Gangalapudi, Vineela
    Esposito, Dominic
    Jones, Jane
    Procter, Lauren
    O'Neill, Maura
    Jenkins, Lisa M.
    Tarasova, Nadya I.
    Wei, Jun S.
    McMahon, James B.
    O'Keefe, Barry R.
    Hawley, Robert G.
    Khan, Javed
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [44] Characterization of the cell death mechanism after silencing of PAX3-FOXO1 in alveolar rhabdomyosarcoma using a CRISPR-Cas mediated knockout approach
    Wachtel, Marco
    Niggli, Felix
    Schaefer, Beat
    CANCER RESEARCH, 2015, 75
  • [45] TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma
    Gabriel Gallo-Oller
    Guillem Pons
    Júlia Sansa-Girona
    Natalia Navarro
    Patricia Zarzosa
    Lia García-Gilabert
    Paula Cabré-Fernandez
    Gabriela Guillén Burrieza
    Lorena Valero-Arrese
    Miguel F. Segura
    José M. Lizcano
    José Sánchez de Toledo
    Lucas Moreno
    Soledad Gallego
    Josep Roma
    Experimental Hematology & Oncology, 13
  • [46] Endogenous HiBiT-tagging of PAX3-FOXO1 identifies potent suppressors of PAX3-FOXO1 protein levels by high-throughput screening
    Kim, Yong Yean
    Hawley, Robert G.
    Churiwal, Mehal
    Hawley, Teresa S.
    Evans, Christine N.
    Chari, Raj
    Milewski, David
    Sinniah, Ranuka
    Song, Young K.
    Chou, Hsien-Chao
    Wen, Xinyu
    Pang, Ying
    Wu, Jing
    Thomas, Craig J.
    Wei, Jun S.
    Ceribelli, Michele
    Khan, Javed
    CANCER RESEARCH, 2023, 83 (07)
  • [47] The PAX3-FOXO1 oncogene drives aneuploidy and overrides aneuploidy-associated proliferative defects in alveolar rhabdomyosarcoma
    Hollenbach, Andrew D.
    Loupe, Jacob M.
    Miller, Patrick J.
    Bonner, Benjamin P.
    Maggi, Elaine C.
    Vijayaraghavan, Jyothi
    Zabaleta, Jovanny
    Taylor, Christopher M.
    Miller, Fern
    Crabtree, Judy S.
    CANCER RESEARCH, 2016, 76
  • [48] Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
    Loupe, J. M.
    Miller, P. J.
    Ruffin, D. R.
    Stark, M. W.
    Hollenbach, A. D.
    ONCOGENESIS, 2015, 4 : e145 - e145
  • [49] TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma
    Gallo-Oller, Gabriel
    Pons, Guillem
    Sansa-Girona, Julia
    Navarro, Natalia
    Zarzosa, Patricia
    Garcia-Gilabert, Lia
    Cabre-Fernandez, Paula
    Burrieza, Gabriela Guillen
    Valero-Arrese, Lorena
    Segura, Miguel F.
    Lizcano, Jose M.
    de Toledo, Jose Sanchez
    Moreno, Lucas
    Gallego, Soledad
    Roma, Josep
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [50] KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
    Yong Yean Kim
    Berkley E. Gryder
    Ranuka Sinniah
    Megan L. Peach
    Jack F. Shern
    Abdalla Abdelmaksoud
    Silvia Pomella
    Girma M. Woldemichael
    Benjamin Z. Stanton
    David Milewski
    Joseph J. Barchi
    John S. Schneekloth
    Raj Chari
    Joshua T. Kowalczyk
    Shilpa R. Shenoy
    Jason R. Evans
    Young K. Song
    Chaoyu Wang
    Xinyu Wen
    Hsien-Chao Chou
    Vineela Gangalapudi
    Dominic Esposito
    Jane Jones
    Lauren Procter
    Maura O’Neill
    Lisa M. Jenkins
    Nadya I. Tarasova
    Jun S. Wei
    James B. McMahon
    Barry R. O’Keefe
    Robert G. Hawley
    Javed Khan
    Nature Communications, 15
12345